Maxime P Look

Maxime P Look

UNVERIFIED PROFILE

Are you Maxime P Look?   Register this Author

Register author
Maxime P Look

Maxime P Look

Publications by authors named "Maxime P Look"

Are you Maxime P Look?   Register this Author

59Publications

1859Reads

28Profile Views

LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.

Mol Oncol 2016 10 25;10(8):1363-73. Epub 2016 Jul 25.

Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423197PMC
October 2016

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

Pharmacogenomics 2016 08 29;17(13):1391-403. Epub 2016 Jul 29.

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2016-0082DOI Listing
August 2016

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.

Oncotarget 2016 May;7(20):29166-76

Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045386PMC
May 2016

SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy.

Am J Cancer Res 2016 15;6(2):270-84. Epub 2016 Jan 15.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859659PMC
May 2016

Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model.

J Clin Epidemiol 2016 Jan 16;69:40-50. Epub 2015 May 16.

Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire ST5 5BG, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2015.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688112PMC
January 2016

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Mol Oncol 2016 Jan 7;10(1):24-39. Epub 2015 Aug 7.

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528925PMC
January 2016

Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.

Horm Cancer 2014 Dec 15;5(6):405-13. Epub 2014 Aug 15.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12672-014-0196-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228172PMC
December 2014

Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice.

Breast Cancer Res Treat 2014 Nov 30;148(1):19-31. Epub 2014 Sep 30.

Department of Medical Oncology and Cancer Genomics Centre, Erasmus University Medical Center - Daniel den Hoed Cancer Center, 3000 CA, Rotterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3142-0DOI Listing
November 2014

Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.

Stat Med 2014 Sep 1;33(22):3844-58. Epub 2014 May 1.

University of Leicester, Department of Health Sciences, Adrian Building, University Road, Leicester LE1 7RH, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.6191DOI Listing
September 2014

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.

J Natl Cancer Inst 2014 Feb 7;106(2):djt376. Epub 2014 Jan 7.

Affiliations of authors: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (NQL, MPL, MS, RBHB, TDM, AMS, JWMM, JAF, AU); Department of Neurology (CS, TML) and Postgraduate School of Molecular Medicine (NQL, RBHB, TDM, AMS, JWMM, JAF, AU), Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Radiation Oncology (PNS) and Department of Laboratory Medicine (FCGJS), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden (BKL); Department of Oncology/Pathology, Karolinska Institute, Stockholm, Sweden (BKL); Clinical Experimental Oncology Laboratory, National Cancer Centre Giovanni Paolo II, Bari, Italy (AM, AP); Translational Cancer Research Unit, Oncology Center, GZA Hospitals St-Augustinus, Antwerp, Belgium (LYD, SJVL); Netherlands Proteomics Centre, Utrecht, The Netherlands (NQL, AU); Cancer Genomics Centre, Utrecht, The Netherlands (MS, AMS, JWMM, JAF, AU); Center for Translational Molecular Medicine, Eindhoven, The Netherlands (RBHB, JAF, AU).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/early/2014/01/06/jnci
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/djt376
Publisher Site
http://dx.doi.org/10.1093/jnci/djt376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952199PMC
February 2014

LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.

Endocr Relat Cancer 2014 Feb 16;21(1):101-12. Epub 2014 Jan 16.

Departments of Radiation Oncology, Laboratory Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/downloadpdf/journals/erc/21/1
Web Search
http://www.jbc.org/content/274/18/12692
Web Search
https://erc.bioscientifica.com/view/journals/erc/21/1/101.xm
Publisher Site
http://dx.doi.org/10.1530/ERC-13-0183DOI Listing
February 2014

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.

Breast Cancer Res Treat 2013 May 17;139(1):39-49. Epub 2013 Apr 17.

Department of Medical Oncology, Erasmus MC Cancer Institute, Room Be424, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2529-7DOI Listing
May 2013

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.

Breast Cancer Res Treat 2012 Jun 12;133(3):843-51. Epub 2011 Jul 12.

Department of Medical Oncology, Josephine Nefkens Institute and Daniel den Hoed Cancer Center, Erasmus MC, Building BE, Room 400, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1663-3DOI Listing
June 2012

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study.

Breast Cancer Res 2010 1;12(6):R103. Epub 2010 Dec 1.

Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, GE, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046448PMC
September 2011

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.

Breast Cancer Res Treat 2011 May 19;127(1):43-51. Epub 2010 May 19.

Department of Medical Oncology, Erasmus Medical Center Rotterdam, Josephine Nefkens Institute and Cancer Genomics Centre, Dr. Molewaterplein 50, Be 4.02 (lab)/4.35b (office), PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0940-xDOI Listing
May 2011

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.

Breast Cancer Res 2009 ;11(5):R75

Laboratory of Cancer Biology and Genetics, NCI, NIH, Room 5046, 37 Convent Drive, Bethesda, Maryland 20892-4264, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790856PMC
March 2010

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study.

BMC Cancer 2009 Sep 10;9:322. Epub 2009 Sep 10.

University of Copenhagen, Faculty of Life Sciences, Department of Veterinary Disease Biology, Ridebanevej 9, DK-1870 Frederiksberg C, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-9-322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754488PMC
September 2009

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

Mol Cell Proteomics 2009 Jun 27;8(6):1278-94. Epub 2009 Mar 27.

Erasmus Medical Center Rotterdam, Josephine Nefkens Inst., Dept. of Medical Oncology, Laboratory of Genomics and Proteomics of Breast Cancer, Dr. Molewaterplein 50, Be 430c, P. O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M800493-MCP200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690491PMC
June 2009

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.

J Clin Oncol 2009 Feb 15;27(4):542-9. Epub 2008 Dec 15.

Department of Pathology, Cancer Genomics Center, Josephine Nefkens Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.1462DOI Listing
February 2009

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.

Breast Cancer Res Treat 2009 Jan 26;113(2):253-60. Epub 2008 Feb 26.

Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Room Be 432, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-9934-3DOI Listing
January 2009

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.

Proc Natl Acad Sci U S A 2008 Sep 28;105(35):13021-6. Epub 2008 Aug 28.

Department of Medical Oncology, Erasmus Medical Center Rotterdam, Josephine Nefkens Institute, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0803304105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529088PMC
September 2008

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.

Endocr Relat Cancer 2008 Mar;15(1):101-11

Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-07-0080DOI Listing
March 2008

Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.

Mol Cell Endocrinol 2007 Sep 17;276(1-2):63-70. Epub 2007 Jul 17.

Department of Internal Medicine, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2007.06.007DOI Listing
September 2007

Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods.

J Clin Epidemiol 2007 May 5;60(5):431-9. Epub 2007 Feb 5.

Centre for Medical Statistics and Health Evaluation, School of Health Sciences, University of Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2006.09.009DOI Listing
May 2007

Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.

Head Neck 2007 Apr;29(4):341-50

Department of Otolaryngology-Head and Neck Surgery, Erasmus MC Daniel den Hoed, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.20527DOI Listing
April 2007

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.

Clin Cancer Res 2006 Dec 17;12(23):7054-8. Epub 2006 Nov 17.

Department of Veterinary Pathobiology, The Royal Veterinary and Agricultural University, Frederiksberg C, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0950DOI Listing
December 2006

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Clin Cancer Res 2003 Feb;9(2):827-36

Department of Medical Oncology, Erasmus Medical Center Rotterdam (Daniel den Hoed Kliniek/Josephine Nefkens Institute), 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
February 2003

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.

Cancer Res 2003 Jan;63(2):337-41

Erasmus MC-Daniel den Hoed, Department of Medical Oncology, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
January 2003